English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Cellular Prion Protein Mediates α-Synuclein Uptake, Localization, and Toxicity In Vitro and In Vivo

Thom, T., Schmitz, M., Fischer, A.-L., Correia, A., Correia, S., Llorens, F., et al. (2022). Cellular Prion Protein Mediates α-Synuclein Uptake, Localization, and Toxicity In Vitro and In Vivo. Movement Disorders, 37(1), 39-51. doi:10.1002/mds.28774.

Item is

Basic

show hide
Genre: Journal Article
Other : Cellular Prion Protein Mediates alpha-Synuclein Uptake, Localization, and Toxicity In Vitro and In Vivo

Files

show Files
hide Files
:
Cellular Prion Protein Mediates α‐Synuclein Uptake, Localization, and Toxicity In Vitro and In Vivo.pdf (Publisher version), 8MB
Name:
Cellular Prion Protein Mediates α‐Synuclein Uptake, Localization, and Toxicity In Vitro and In Vivo.pdf
Description:
-
OA-Status:
Hybrid
Visibility:
Public
MIME-Type / Checksum:
application/pdf / [MD5]
Technical Metadata:
Copyright Date:
-
Copyright Info:
-

Locators

show

Creators

show
hide
 Creators:
Thom, Tobias, Author
Schmitz, Matthias, Author
Fischer, Anna-Lisa, Author
Correia, Angela, Author
Correia, Susana, Author
Llorens, Franc, Author
Pique, Anna-Villar, Author
Möbius, Wiebke1, Author           
Domingues, Renato, Author
Zafar, Saima, Author
Stoops, Erik, Author
Silva, Christopher J., Author
Fischer, Andre, Author
Outeiro, Tiago Fleming1, Author           
Zerr, Inga, Author
Affiliations:
1Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Max Planck Society, ou_3350301              

Content

show
hide
Free keywords: -
 Abstract: Background

The cellular prion protein (PrPC) is a membrane-bound, multifunctional protein mainly expressed in neuronal tissues. Recent studies indicate that the native trafficking of PrPC can be misused to internalize misfolded amyloid beta and α-synuclein (aSyn) oligomers.

Objectives

We define PrPC's role in internalizing misfolded aSyn in α-synucleinopathies and identify further involved proteins.

Methods

We performed comprehensive behavioral studies on four transgenic mouse models (ThySyn and ThySynPrP00, TgM83 and TgMPrP00) at different ages. We developed PrPC-(over)-expressing cell models (cell line and primary cortical neurons), used confocal laser microscopy to perform colocalization studies, applied mass spectrometry to identify interactomes, and determined disassociation constants using surface plasmon resonance (SPR) spectroscopy.

Results

Behavioral deficits (memory, anxiety, locomotion, etc.), reduced lifespans, and higher oligomeric aSyn levels were observed in PrPC-expressing mice (ThySyn and TgM83), but not in homologous Prnp ablated mice (ThySynPrP00 and TgMPrP00). PrPC colocalized with and facilitated aSyn (oligomeric and monomeric) internalization in our cell-based models. Glimepiride treatment of PrPC-overexpressing cells reduced aSyn internalization in a dose-dependent manner. SPR analysis showed that the binding affinity of PrPC to monomeric aSyn was lower than to oligomeric aSyn. Mass spectrometry-based proteomic studies identified clathrin in the immunoprecipitates of PrPC and aSyn. SPR was used to show that clathrin binds to recombinant PrP, but not aSyn. Experimental disruption of clathrin-coated vesicles significantly decreased aSyn internalization.

Conclusion

PrPC's native trafficking can be misused to internalize misfolded aSyn through a clathrin-based mechanism, which may facilitate the spreading of pathological aSyn. Disruption of aSyn-PrPC binding is, therefore, an appealing therapeutic target in α-synucleinopathies.

Details

show
hide
Language(s): eng - English
 Dates: 2021-08-272022
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: DOI: 10.1002/mds.28774
 Degree: -

Event

show

Legal Case

show

Project information

show hide
Project name : This study was funded by the Alzheimer's Drug Discovery Foundation (Grant 201810-2017419 to F.L. and I.Z.); the Instituto Carlos III (Grants CP16/00041 and PI19/00144) to F.L.; the Robert Koch Institute through funds from the German Federal Ministry of Health (Grant 1369–341) to I.Z.; the Spanish Ministry of Health, Instituto Carlos III (Fondo de Investigación Sanitaria Grant PI14/00757); and the U.S. Department of Agriculture, Agricultural Research Service (CRIS 2030-32000-010-00D). The authors wish to acknowledge the assistance of Ms. Melissa Erickson-Beltran in preparing this manuscript. A.F. and T.F.O. are supported by the Deutsche Forschungsgemeinschaft (German Research Foundation) under Germany's Excellence Strategy EXC 2067/1-390729940 and by SFB1286 (project B 6,8). All authors have read the manuscript and have indicated consent for publication. Open access funding enabled and organized by Projekt DEAL.
Grant ID : -
Funding program : -
Funding organization : -

Source 1

show
hide
Title: Movement Disorders
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: New York, NY : John Wiley & Sons
Pages: - Volume / Issue: 37 (1) Sequence Number: - Start / End Page: 39 - 51 Identifier: ISSN: 0885-3185
CoNE: https://pure.mpg.de/cone/journals/resource/954925551353